Status:
UNKNOWN
SLPI for Prostate Cancer
Lead Sponsor:
University of Florence
Collaborating Sponsors:
Istituto per lo Studio, la Prevenzione e la Rete Oncologica
Azienda Ospedaliero-Universitaria Careggi
Conditions:
Prostate Cancer
Prostatic Neoplasm
Eligibility:
MALE
18+ years
Brief Summary
Exploratory study of SLPI expression in human prostate cancer patients This is a no-profit exploratory study about the expression of SLPI in human prostate cancer patients that will enroll about 200 p...
Detailed Description
Prostate cancer (PC) is a heterogeneous disease that occurs more frequently in elderly men. Prostate cancer is usually localized and it has a slow progression; thus, the patient may not suffer from an...
Eligibility Criteria
Inclusion
- Patients with prostate carcinoma.
- Patients with Benign Prostatic Hyperplasia.
- Male subjects older that 50 years without prostate or neoplastic diseases.
Exclusion
- Male subjects younger that 50 years without prostate disease.
- Male subjects with neoplastic diseases either than prostate.
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2024
Estimated Enrollment :
280 Patients enrolled
Trial Details
Trial ID
NCT04854343
Start Date
December 1 2020
End Date
July 1 2024
Last Update
May 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Careggi University Hospital
Florence, Tuscany, Italy, 50134